Abstract: A method and device for determining the glucose level in living tissue are based on measuring the response of the tissue an electric field as well as temperature measurements. In order to improve accuracy, it has been found that measurements in at least three frequency ranges between 1 kHz and 200 kHz, 0.2 MHz an 100 MHz as well as above 1 GHz should be combined since the response of the tissue in these different frequency ranges is ruled by differing mechanisms.
Type:
Grant
Filed:
April 17, 2009
Date of Patent:
February 2, 2016
Assignee:
BIOVOTION AG
Inventors:
Andreas Caduff, Mark Stuart Talary, Martin Müller, Oscar De Feo
© 2024 Justia
